Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.

Saved in:
Bibliographic Details
Title: Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.
Authors: Wu, Jerry T.1 (AUTHOR) jerry.wu@nih.gov, Cheuk, Adam1 (AUTHOR) cheukt@gmail.com, Isanogle, Kristine2 (AUTHOR) kristine.isanogle@nih.gov, Robinson, Christina2 (AUTHOR) christina.robinson2@nih.gov, Zhang, Xiaohu3 (AUTHOR) xiaohu.zhang@nih.gov, Ceribelli, Michele3 (AUTHOR) michele.ceribelli@nih.gov, Beck, Erin3 (AUTHOR) erin.beck2@nih.gov, Shinn, Paul3 (AUTHOR) shinnp@mail.nih.gov, Klumpp-Thomas, Carleen3 (AUTHOR) carleen.klumpp-thomas@nih.gov, Wilson, Kelli M.3 (AUTHOR) kelli.wilson@nih.gov, McKnight, Crystal3 (AUTHOR) crystal.mcknight@nih.gov, Itkin, Zina3 (AUTHOR) zina.itkin@nih.gov, Sotome, Hiroshi4 (AUTHOR) h-sohtome@taiho.co.jp, Hirai, Hiroshi4 (AUTHOR) hiroshi-hirai@taiho.co.jp, Calleja, Elizabeth5 (AUTHOR) ecalleja@taihooncology.com, Wacheck, Volker5 (AUTHOR) vwacheck@taihooncology.com, Gouker, Brad2 (AUTHOR) difilips@mail.nih.gov, Peer, Cody J.6 (AUTHOR) natalia.corvalan@nih.gov, Corvalan, Natalia6 (AUTHOR), Milewski, David1 (AUTHOR) david.milewski@nih.gov
Source: Cancers. Aug2023, Vol. 15 Issue 16, p4034. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers15164034